← Back to Patent Explorer
US4084001A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmacologically active compounds

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1976-11-23
•
Granted: 1978-04-11
•
Expires: 1996-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds are substituted S-(aminoalkyl)isothioureas which are histamine H2-antagonists. Two specific compounds of the present invention are S-[6-(N'-methylthioureido)hexyl]isothiourea and S-[5-(N'-cyano-N''-methylguanidino)pentyl]isothiourea.

Inventors

  • 👤 Graham John Durant
  • 👤 Charon Robin Ganellin
  • 👤 Robert John Ife

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 01:33
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/96; A; A61; A61P; A61P43/00; C07C; C07C335/00; C07C335/30; C07C335/32

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 32 words
A compound of the formula ##STR8## wherein n is an integer from 3 to 6; R is lower alkyl or ##STR9## X is sulphur; or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 32 words
A compound of the formula ##STR8## wherein n is an integer from 3 to 6; R is lower alkyl or ##STR9## X is sulphur; or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 11 words
A compound of claim 1 wherein n is 5 or 6.
Claim 4
Dependent Claim 12 words
A compound of claim 1, said compound being a salt of S-[6-(N'-methylthioureido)hexyl]isothiourea.
Claim 5
Dependent Claim 12 words
A compound of claim 1, said compound being a salt of S-[5-(N'-methylthioureido)pentyl]isothiourea.
Claim 6
Dependent Claim 17 words
A compound of claim 1 which is in the form of a pharmaceutically acceptable acid addition salt.
Claim 7
Dependent Claim 42 words
A pharmaceutical composition to block histamine H 2 -receptors comprising in an effective amount to block said receptors a compound of claim 1 in the form of a pharmaceutically acceptable acid addition salt in combination with a pharmaceutically acceptable diluent or carrier.
Claim 8
Dependent Claim 13 words
A pharmaceutical composition of claim 6 in unit dosage form for oral administration.
Claim 9
Dependent Claim 30 words
A method of blocking histamine H 2 -receptors which comprises administering to an animal in need thereof in an effective amount to block said receptors a compound of claim 1.
Claim 10
Dependent Claim 26 words
A method of treating inflammation which comprises administering to an animal in need thereof in an effective amount to treat inflammation a compound of claim 1.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-04-10 1981-10-10 1982-04-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-04-10 1985-10-10 1986-04-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-04-10 1989-10-10 1990-04-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag